Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Supervalu Devalues Sharply After Bad Earnings Miss

Minneapolis-based grocery chain Supervalu (SVU) became a super value on the market Wednesday – in a bad way – when it reported a huge miss on its earnings report for its Q1 of FY13. The stock is down more than 35 percent premarket Thursday in the wake of that news and the steps the company is taking to combat its hemorrhaging.


For the quarter than ended June 16, Supervalu reported revenue of $10.6 billion, which was $200 million shy of estimates, and the company’s earnings per share (EPS) was listed at 19 cents ($41 million), which was one-half of expected (38 cents). This news is spreading to other grocery chain stocks as well, as Safeway and Kroger are looking down Thursday by modest numbers.

This huge miss is badly affecting several hedge funds, including Ron Gutfleish’s Elm Ridge Capital and Chase Coleman’s Tiger Global Management, LLC. These two funds were invested a combined $86 million in the stock, with Elm Ridge increasing its share hold by 25 percent as of the end of March, and Tiger jumping all-in during the first quarter of 2012. In fact, each of the top five hedge fund holdings increased their shareholdings early this year, several by more than 100 percent.

Talk about a lead balloon.

In response  to its own report, Supervalu stated that it was suspending its dividend, will consider “deeper” cost savings and “more flexible financing facilities” in order to improve cash flow.

CEO Craig Herkert said in a press release, “While our shift to a fair price plus promotion strategy is right for our business, it is essential that we move even more aggressively to lower prices, and anticipate and respond to competitor actions. We expect our business transformation to meet our customers demands for great quality at lower prices. We intend to do this while remaining profitable, continuing to pay down debt and investing the capital to maintain and enhance our stores and related assets. Accordingly, we will be pursuing deeper and more structural cost savings initiatives. Also, we are adopting more flexible financing facilities, reducing our near-term capital expenditures and suspending our dividend. We are committed to generating operating cash flows of more than $1 billion annually and meeting or exceeding our debt reduction targets. And, to assure we are evaluating the full range of opportunities available to us to create value for shareholders, the Company’s Board and management, together with its financial advisors, are reviewing strategic alternatives for our business.”

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!